IRIDEX Corporation

NasdaqCM:IRIX Stock Report

Market Cap: US$18.6m

IRIDEX Management

Management criteria checks 1/4

IRIDEX's CEO is Patrick Mercer, appointed in May 2024, has a tenure of 2.17 years. total yearly compensation is $901.90K, comprised of 42.6% salary and 57.4% bonuses, including company stock and options. directly owns 1% of the company’s shares, worth $185.33K. The average tenure of the management team and the board of directors is 2 years and 1.5 years respectively.

Key information

Patrick Mercer

Chief executive officer

US$901.9k

Total compensation

CEO salary percentage42.65%
CEO tenure2.2yrs
CEO ownership1.0%
Management average tenure2yrs
Board average tenure1.5yrs

Recent management updates

Recent updates

New Narrative • Feb 06

Growing Laser Glaucoma Adoption And Cost Restructuring Will Support A Stronger Long Term Outlook

Catalysts About IRIDEX IRIDEX develops and sells ophthalmic laser systems and related disposable products for glaucoma and retina procedures worldwide. What are the underlying business or industry changes driving this perspective?
Analysis Article • Jun 11

Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

IRIDEX Corporation ( NASDAQ:IRIX ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article • May 14

Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Seeking Alpha • Mar 28

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Summary Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out in more than one transaction "soon." The glaucoma business line is highly promising but likely needs to be in the hands of a bigger company to reach its full potential. The entire business may be worth double the current share prices, in line with what Topcon paid three years ago to acquire a 10% stake. Read the full article on Seeking Alpha
Analysis Article • Feb 14

Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

You may think that with a price-to-sales (or "P/S") ratio of 0.7x IRIDEX Corporation ( NASDAQ:IRIX ) is definitely a...
Analysis Article • Oct 04

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Analysis Article • Aug 12

Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

IRIDEX Corporation ( NASDAQ:IRIX ) shareholders that were waiting for something to happen have been dealt a blow with a...
Analysis Article • Apr 14

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article • Oct 12

We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Feb 25

Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

CEO Compensation Analysis

How has Patrick Mercer's remuneration changed compared to IRIDEX's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 04 2026n/an/a

-US$3m

Jan 03 2026US$902kUS$385k

-US$4m

Sep 27 2025n/an/a

-US$5m

Jun 28 2025n/an/a

-US$5m

Mar 29 2025n/an/a

-US$7m

Dec 28 2024US$1mUS$360k

-US$9m

Sep 28 2024n/an/a

-US$11m

Jun 29 2024n/an/a

-US$11m

Mar 30 2024n/an/a

-US$11m

Dec 30 2023US$518kUS$336k

-US$10m

Sep 30 2023n/an/a

-US$8m

Jul 01 2023n/an/a

-US$8m

Apr 01 2023n/an/a

-US$7m

Dec 31 2022US$568kUS$317k

-US$8m

Oct 01 2022n/an/a

-US$9m

Jul 02 2022n/an/a

-US$9m

Apr 02 2022n/an/a

-US$6m

Jan 01 2022US$765kUS$317k

-US$5m

Oct 02 2021n/an/a

-US$3m

Jul 03 2021n/an/a

-US$3m

Apr 03 2021n/an/a

-US$7m

Jan 02 2021US$472kUS$316k

-US$6m

Sep 26 2020n/an/a

-US$8m

Jun 27 2020n/an/a

-US$8m

Mar 28 2020n/an/a

-US$7m

Dec 28 2019US$500kUS$277k

-US$9m

Compensation vs Market: Patrick's total compensation ($USD901.90K) is above average for companies of similar size in the US market ($USD659.91K).

Compensation vs Earnings: Patrick's compensation has been consistent with company performance over the past year.

CEO

Patrick Mercer (54 yo)

2.2yrs
Tenure
US$901,900
Compensation

Mr. Patrick Mercer is Chief Executive Officer of IRIDEX Corporation from October 1, 2024 and serves as its President since May 22, 2024 and was its Chief Operating Officer since September 2018 until Octobe...

Leadership Team

NamePositionTenureCompensationOwnership
Scott Shuda
Executive Chairman7.3yrsUS$113.74k0.74%
$ 138.6k
Patrick Mercer
CEO, President & Director2.2yrsUS$901.90k1.0%
$ 185.3k
Romeo Dizon
Chief Financial Officer1.3yrsUS$526.21k0.77%
$ 142.6k
Bassem BouHabib
SVP of International Sales & Business Development6.9yrsUS$550.83k0.64%
$ 119.3k
Leigh Salvo
Head of Investor Relationsno datano datano data
2.0yrs
Average Tenure
57.5yo
Average Age

Experienced Management: IRIX's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Scott Shuda
Executive Chairman7.3yrsUS$113.74k0.74%
$ 138.6k
Patrick Mercer
CEO, President & Director1.5yrsUS$901.90k1.0%
$ 185.3k
William Moore
Director1.3yrsUS$86.41k2.31%
$ 430.1k
Beverly Huss
Independent Director4.3yrsUS$87.36k0.53%
$ 99.1k
Yu-Hao Chen
Independent Director1.3yrsUS$74.04k0%
$ 0
1.5yrs
Average Tenure
61yo
Average Age

Experienced Board: IRIX's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/15 03:02
End of Day Share Price 2026/07/15 00:00
Earnings2026/04/04
Annual Earnings2026/01/03

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IRIDEX Corporation is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Scott HenryRoth Capital Partners
Joseph MundaSidoti & Company, LLC